- Home
- ESLA vs ZCMD Comparison
ESLA vs ZCMD Comparison
Compare ESLA & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESLA
- ZCMD
- Stock Information
- Founded
- ESLA 2021
- ZCMD 2012
- Country
- ESLA United States
- ZCMD China
- Employees
- ESLA N/A
- ZCMD N/A
- Industry
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- ZCMD Other Consumer Services
- Sector
- ESLA Health Care
- ZCMD Real Estate
- Exchange
- ESLA Nasdaq
- ZCMD Nasdaq
- Market Cap
- ESLA 35.5M
- ZCMD 32.8M
- IPO Year
- ESLA N/A
- ZCMD 2020
- Fundamental
- Price
- ESLA $1.07
- ZCMD $1.08
- Analyst Decision
- ESLA Strong Buy
- ZCMD
- Analyst Count
- ESLA 1
- ZCMD 0
- Target Price
- ESLA $16.00
- ZCMD N/A
- AVG Volume (30 Days)
- ESLA 518.6K
- ZCMD 4.1K
- Earning Date
- ESLA 06-17-2025
- ZCMD 01-01-0001
- Dividend Yield
- ESLA N/A
- ZCMD N/A
- EPS Growth
- ESLA N/A
- ZCMD N/A
- EPS
- ESLA N/A
- ZCMD N/A
- Revenue
- ESLA N/A
- ZCMD $15,864,773.00
- Revenue This Year
- ESLA $101.09
- ZCMD N/A
- Revenue Next Year
- ESLA N/A
- ZCMD N/A
- P/E Ratio
- ESLA N/A
- ZCMD N/A
- Revenue Growth
- ESLA N/A
- ZCMD N/A
- 52 Week Low
- ESLA $0.63
- ZCMD $0.95
- 52 Week High
- ESLA $3.23
- ZCMD $2.97
- Technical
- Relative Strength Index (RSI)
- ESLA 55.18
- ZCMD 41.24
- Support Level
- ESLA $0.78
- ZCMD $1.02
- Resistance Level
- ESLA $1.18
- ZCMD $1.26
- Average True Range (ATR)
- ESLA 0.10
- ZCMD 0.05
- MACD
- ESLA 0.00
- ZCMD -0.01
- Stochastic Oscillator
- ESLA 71.28
- ZCMD 20.70
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.